Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway

Pediatric Diabetes

Volumn 7, Issue 5, 2006, Pages 239-246

  Skrivarhaug, Torild ^a,b   Bangstad, Hans Jacob ^a,b   Stene, Lars C ^a,b,c   Sandvik, Leiv ^a   Hanssen, Kristian F ^a,b,d   Joner, Geir ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Diabetes Research Centre   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Child onset; Diabetic nephropathy; Norway; Type 1 diabetes mellitus

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ALBUMINURIA; ARTICLE; CIGARETTE SMOKING; CLINICAL EXAMINATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION;

EID: 33750110665     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2006.00204.x     Document Type: Article

References (43)

1. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage - The Steno Hypothesis. Diabetologia 1989: 32: 219-226.
2. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type-1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 1987: 30: 144-148.
3. Borch-Johnsen K, Kreiner S. Proteinuria - value as predictor of cardiovascular mortality in insulin-dependent diabetes-mellitus. Br Med J 1987: 294: 1651-1654.
4. Borch-Johnsen K, Andersen PK, Deckert T et al. The effect of proteinuria on relative mortality in type-1 (insulin-dependent) diabetes mellitus. Diabetologia 1985: 28: 590-596.
5. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E. Proteinuria and mortality in diabetes - the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med 1995: 12: 149-155.
6. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in type-1 (insulin-dependent) diabetic-patients in Denmark. Diabetes 1987: 36: 205-209.
7. Krolewski AS, Warram JH, Christlieb AR, Busic EJ, Kahn CR. The changing natural-history of nephropathy in type-1 diabetes. Am J Med 1985: 78: 785-794.
8. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Udvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes-mellitus. N Engl J Med 1994: 330: 15-18.
9. Hovind P, Tarnow L, Rossing K et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003: 26: 1258-1264.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N Engl J Med 1993: 329: 977-986.
11. Mathisen ER, Hommel E, Giese J, Parving HH. Efficacy of Capopril in postponing nephropathy in normotensive insulin-dependent diabetic-patients with microalbuminuria. Br Med J 1991: 303: 81-87.
12. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of Captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes-mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994: 271: 275-279.
13. Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenæs Ø. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. Acta Endocrinol 1988: 117: 19-25.
14. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin-treatment on the development of microvascular complications of diabetes-mellitus. N Engl J Med 1993: 329: 304-309.
15. Feldt-Rasmussen B, Mathisen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: An update of the Steno Studies. Diabetologia 1991: 34: 164-170.
16. Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type-1 (insulin-dependent) diabetic-patients. Diabetologia 1992: 35: 1049-1054.
17. Joner G, Søvik O. Increasing incidence of diabetes mellitus in Norwegian children 0-14 years of age 1973-1982. Diabetologia 1989: 32: 79-83.
18. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987: 31: 673-689.
19. Hovind P, Tarnow L, Rossing P et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004: 328: 1105-1109.
20. Stephenson JM, Fuller JH. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia 1994: 37: 278-285.
21. Orchard TJ, Dorman JS, Maser RE et al. Prevalence of complications in IDDM by sex and duration - Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990: 39: 1116-1124.
22. Walsh MG, Zgibor J, Borch-Johnsen K, Orchard TJ; on behalf of the Diacomp Investigators. A multinational comparison of complications assessment in type 1 diabetes. Diabetes Care 2004: 27: 1610-1617.
23. American Diabetes Association. Clinical practice recommendations 2005. Diabetes Care 2005: 28 (Suppl. 1): S4-S36.
24. Dyer PH, Lloyd CE, Lancashire RJ, Bain SC, Barnett AH. Factors associated with clinic non-attendance in adults with type 1 diabetes mellitus. Diabet Med 1997: 15: 339-343.
25. Tarnow L, Kjeld T, Knudsen E, Major-Pedersen A, Parving HH. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type 1 diabetic patients. Diabetologia 2000: 43: 794-799.
26. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982: 72: 375-380.
27. Mulec H, Johnsen SA, Wiklund O, Bjorck S. Cholesterol: A renal risk factor in diabetic nephropathy? Am J Kidney Dis 1993: 22: 196-201.
28. Krolewski AS, Warram JH, Christlieb AR. Hypercholesterolemia - a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994: 45: S125-S131.
29. Wellman KF, Volk BW. Renal changes in experimental hypercholesterolemia in normal and in subdiabetic rabbits. II. Long term studies. Lab Invest 1971: 24: 144-155.
30. Jenkins AJ, Lyons TJ, Zheng D et al. Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy. Kidney Int 2003: 64: 817-828.
31. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: Insights from experimental data and clinical studies. Diabetes Metab 2000: 26: 254-264.
32. Schalwijk CG, Poland DCW, van Dijk W et al. Plasma concentration of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation. Diabetologia 1999: 42: 351-357.
33. Saraheimo M, Teppo A-M, Forsblom C, Fagerudd J, Groop P-H. Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 2003: 46: 1402-1407.
34. Myrup B, De Maat M, Rossing P, Gram J, Kluft C, Jespersen J. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res 1996: 81: 485-490.
35. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000: 58: 1703-1710.
36. Stehouwer CDA, Gall MA, Twisk JWR, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes - progressive, interrelated, and independently associated with risk of death. Diabetes 2002: 51: 1157-1165.
37. Haugen OA. Smoking in Norwegian hospitals. Tidsskr Nor Laegeforen 2002: 122: 193-195.
38. Ritz E, Ogata H, Orth SR. Smoking: A factor promoting onset and progression of diabetic nephropathy. Diabetes Metab 2000: 26: 54-63.
39. Bangstad HJ, Østerby R, Rudberg S, Hartmann A, Brabrand K, Hanssen KF. Kidney function and glomerulopathy over 8 years in young patients with type 1 (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 2002: 45: 253-261.
40. Hovind P, Rossing P, Tarnow L, Parving HH. Smoking and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 2003: 26: 911-916.
41. Williamson JR, Rowold E, Chang K et al. Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability and collagen cross-linking. Diabetes 1986: 35: 20-27.
42. Swift PGF (ed). ISPAD (International Society For Pediatric and Adolescent Diabetes). Consensus Guidelines for the Management of Children and Adolescents with Diabetes. Report. Zeist, the Netherlands: Publ. Medforum, 2000.
43. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006: 49: 298-305.